Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Clinical trial NCT07209462 · RECRUITING
Trial details
- NCT number
- NCT07209462
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-22
- Primary completion
- 2027-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.